Chronic Condition Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Condition stocks.

Recent Signals

Date Stock Signal Type
2021-04-12 AXSM New 52 Week Low Weakness
2021-04-12 AXSM New 52 Week Closing Low Bearish
2021-04-12 AZN Bollinger Band Squeeze Range Contraction
2021-04-12 AZN Fell Below 20 DMA Bearish
2021-04-12 AZN Fell Below 50 DMA Bearish
2021-04-12 OPCH Fell Below 20 DMA Bearish
2021-04-12 OPCH Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-12 OPCH Bearish Engulfing Bearish
2021-04-12 OPCH Narrow Range Bar Range Contraction
2021-04-12 TTNP New 52 Week Closing Low Bearish
2021-04-12 TTNP New 52 Week Low Weakness
2021-04-12 TTNP MACD Bearish Signal Line Cross Bearish

Recent News for Chronic Condition Stocks

Date Stock Title
Apr 13 AZN Australia shelves plans to buy J&J's one-dose COVID-19 vaccine
Apr 12 AZN Analyst Downgrades AstraZeneca Stock Due to Vaccine Side Effect Concerns
Apr 12 AZN UPDATE 2-Ireland is latest country to restrict use of AstraZeneca vaccine
Apr 12 AZN Doctor on vaccine push: 'These vaccines work extremely well and that’s something to celebrate'
Apr 12 AZN UPDATE 1-Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 - statement
Apr 12 AZN J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots
Apr 12 AZN AstraZeneca’s oral COVID-19 therapy fails in late-stage trial
Apr 12 AZN AstraZeneca Farxiga Drug Doesn't Work Against COVID-19
Apr 12 AZN UPDATE 2-AstraZeneca's diabetes drug Farxiga fails in COVID-19 study
Apr 12 AZN Collateral trade benefit of Biden’s tax reform
Apr 11 AZN UPDATE 1-AstraZeneca says it had positive meeting with EU over vaccine row
Apr 11 AZN RPT-AstraZeneca has not reacted yet to EU letter on vaccines - Corriere
Apr 11 AZN AstraZeneca has not reacted yet to EU letter on vaccines - Corriere
Apr 11 AZN UPDATE 1-S.Korea to resume wider use of AstraZeneca coronavirus vaccine, exclude people under 30
Apr 11 AZN Europe steps up vaccination campaigns after slow start
Apr 11 AZN China considers mixing vaccines to bolster low efficacy
Apr 10 AZN Venezuela paid $64 million to receive vaccines through COVAX -vice president
Apr 10 AZN Benzinga's Bulls And Bears Of The Week: Apple, Chevron, GM, GE, Peloton And More
Apr 10 AZN World Bank commits $2bn for vaccines in developing nations
Apr 10 AZN Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?